Evolus Inc at Wells Fargo Virtual Healthcare Conference Transcript
Please be advised that today's conference is being recorded. Thank you.
Perfect. Hi, everyone. I am Jacob Hughes, specialty pharmaceutical analyst at Wells Fargo. I'm very pleased to introduce our next fireside chat with the bolus Evolus. From the Company we have President and CEO, David Moatazedi; Chief Financial Officer and EVP of Corporate Development, Lauren Silvernail; and VP of Finance, IR and Treasury, Ashwin Agarwal. (Operator Instructions). David, maybe I'll kick it over to you for a brief overview and catch up on the state of the business and then we can jump into Q&A.
Sounds great. Jacob, thank you and Wells Fargo for having Evolus on this fireside chat. It's a pleasure to be here with you all. I'll start by just giving a background on the Company for those of you that are not familiar with Evolus.
It's a company that was formed seven years ago, focused and dedicated to the space of medical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |